Ranbaxy develops new drug delivery system for Cipro
Domestic pharma major Ranbaxy Laboratories Ltd (DRL) has achieved the first breakthrough in its R&D programme. Its new drug delivery system (NDDS) product, once-a-day dosage form of Cirpfloxacin
Domestic pharma major Ranbaxy Laboratories Ltd (DRL) has achieved the first breakthrough in its R&D programme. Its new drug delivery system (NDDS) product, once-a-day dosage form of Cirpfloxacin